156 related articles for article (PubMed ID: 7332914)
1. Comparative clinical trial of sisomicin and gentamicin in serious systemic gram-negative infections.
Lorber R; Danzig M; Malfitan VA
Clin Ther; 1981; 4(4):263-74. PubMed ID: 7332914
[TBL] [Abstract][Full Text] [Related]
2. Prospective double-blind controlled clinical study of sisomicin versus tobramycin.
Schieker KR; Hofmann HF
Pharmatherapeutica; 1981; 2(8):499-503. PubMed ID: 7019928
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sisomicin and gentamicin in the treatment of serious systemic infections.
Leal del Rosal P; Leal del Rosal L; Riosvelasco Carrasco AG; Aguirre Rascon E
Curr Med Res Opin; 1980; 6(10):663-9. PubMed ID: 7428404
[TBL] [Abstract][Full Text] [Related]
4. [Results of the use of a new aminoglycoside antibiotic, sisomicin, in gram negative bacterial respiratory infections].
Lechi A; Arosio E; Mengoli C; Montesi G; Bonato D
Minerva Med; 1979 Sep; 70(41):2821-5. PubMed ID: 492551
[TBL] [Abstract][Full Text] [Related]
5. Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Efficacy and safety.
Herting RL; Lorber RR; Miller M; Danzig MR
Arzneimittelforschung; 1981; 31(2):366-70. PubMed ID: 7194655
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
Weippl G
Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
[TBL] [Abstract][Full Text] [Related]
7. Sisomicin in the treatment of severe or complicated urinary tract infections.
Bailey RR; Peddie B
N Z Med J; 1978 Feb; 87(605):91-4. PubMed ID: 273804
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
10. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin.
Madsen PO; Kjaer TB; Mosegaard A
Urology; 1977 Jun; 9(6):635-8. PubMed ID: 329522
[TBL] [Abstract][Full Text] [Related]
11. [Comparative double-blind trial of sisomicin and gentamicin in the treatment of complicated urinary tract infections (author's transl)].
Niijima T; Kondo K; Okamoto K; Eto K; Momose S; Kumazawa J; Kurokawa K; Fujimura N; Goto H; Sonoda T; Unno R; Machida T; Miyamura R; Saito I; Tahara T; Hosoi Y; Shimano E; Kotera K; Higashitsutsumi M
Jpn J Antibiot; 1979 Apr; 32(4):481-503. PubMed ID: 379383
[No Abstract] [Full Text] [Related]
12. Comparison of activity of sisomicin and gentamicin in mouse protection tests with gram-negative bacilli.
Meyers BR; Hirschman SZ
Antimicrob Agents Chemother; 1976 Aug; 10(2):384-6. PubMed ID: 984779
[TBL] [Abstract][Full Text] [Related]
13. [Clinical, bacteriological and pharmacokinetic study of Sisomicin in the newborn infant].
Sorin M; de Merleire F; Berche P; Daoulas-Lebourdelles F; Veron M
Sem Hop; 1978 Mar; 54(5-8):345-50. PubMed ID: 211630
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
15. [Sisomicin. Bacteriological studies and clinical activity in respiratory, septicemic and urinary infections].
Altucci P; Manguso L; Abbate GF; Alagia I; Catalano G; Leonessa V
G Ital Chemioter; 1977; 24(1-2):23-31. PubMed ID: 615759
[No Abstract] [Full Text] [Related]
16. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
Alegente G; Marchi B; Pieri I; Saturni A; Progenie G; Rubino M
Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931
[TBL] [Abstract][Full Text] [Related]
17. Clinical and bacteriological evaluation of netilmicin in gram-negative infections.
Klastersky J; Meunier-Carpentier F; Coppens-Kahan L; Daneau D; Prevost JM
Antimicrob Agents Chemother; 1977 Oct; 12(4):503-9. PubMed ID: 335960
[TBL] [Abstract][Full Text] [Related]
18. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of cefotaxime versus the combination of gentamicin plus clindamycin in the treatment of polymicrobial soft-tissue surgical sepsis.
Strom PR; Geheber CE; Morris ES; Stone HH
Clin Ther; 1982; 5 Suppl A():26-31. PubMed ID: 6293715
[TBL] [Abstract][Full Text] [Related]
20. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
